Plain-English translation of NCT06807190 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 1 research guide →This study is testing how well Awiqli works and how safe it is in people with diabetes who are receiving it as part of their regular medical care in Japan. Your doctor has already decided that this medication is right for you — this study simply follows you for a year to carefully track how the medication affects your health and blood sugar. Researchers will collect information about any side effects and how well the treatment is working for you.
Once a medication becomes available for patients to use, doctors and researchers want to understand how it performs in real-world settings with different types of patients. This study will show how the medication works when people are using it in their everyday lives, outside of a controlled research lab.
You likely qualify if…
You likely don't qualify if…
You will take Awiqli as prescribed by your doctor — exactly as you would if you were not in the study. The main difference is that over the next year, your doctor will carefully monitor you and collect information about how the medication is working, any side effects you experience, and how your diabetes is controlled. You'll have regular check-ins, and the study team will review your medical records to track your progress.
AI-generated summary from trial data · Oct 3, 2026 · Not medical advice
Japan